Literature DB >> 10327051

The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.

M C Duyndam1, H van Dam, P H Smits, M Verlaan, A J van der Eb, A Zantema.   

Abstract

The adenovirus E1A proteins activate the c-jun promoter through two Jun/ATF-binding sites, jun1 and jun2. P300, a transcriptional coactivator of several AP1 and ATF transcription factors has been postulated to play a role in this activation. Here, we present evidence that p300 can control c-jun transcription by acting as a cofactor for ATF2: (1) Over-expression of p300 was found to stimulate c-jun transcription both in the presence and absence of E1A. (2) Like E1A, p300 activates the c-jun promoter through the junl and jun2 elements and preferentially activates the N-terminal domain of ATF2. (3) Co-immunoprecipitation assays of crude cell extracts indicate that endogenous p300/CBP(-like) proteins and ATF2 proteins are present in a multiprotein complex that can bind specifically to the jun2 element. We further demonstrate that the Stress-Activated-Protein-Kinase (SAPK) target sites of ATF2, Thr69 and Thr71 are not required for the formation of the p300/CBP-ATF2 multiprotein complex. These data indicate that E1A does not inhibit all transcription activation functions of p300, and, in fact, cooperates with p300 in the activation of the ATF2 N-terminus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327051     DOI: 10.1038/sj.onc.1202584

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

1.  A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.

Authors:  R G Vries; M Prudenziati; C Zwartjes; M Verlaan; E Kalkhoven; A Zantema
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

2.  Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Josephine C Dorsman; Alt Zantema
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Cascade of distinct histone modifications during collagenase gene activation.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Alt Zantema
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Critical role of N-terminal end-localized nuclear export signal in regulation of activating transcription factor 2 (ATF2) subcellular localization and transcriptional activity.

Authors:  Chih-Chao Hsu; Chang-Deng Hu
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 5.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

6.  ATF2 - at the crossroad of nuclear and cytosolic functions.

Authors:  Eric Lau; Ze'ev A Ronai
Journal:  J Cell Sci       Date:  2012-06-08       Impact factor: 5.285

7.  An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis.

Authors:  Anindita Bhoumik; Tian-Gui Huang; Vladimir Ivanov; Lisa Gangi; Rui F Qiao; Savio L C Woo; Shu-Hsia Chen; Ze'ev Ronai
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Genome-wide assessment of differential roles for p300 and CBP in transcription regulation.

Authors:  Yolande F M Ramos; Matthew S Hestand; Matty Verlaan; Elise Krabbendam; Yavuz Ariyurek; Michiel van Galen; Hans van Dam; Gert-Jan B van Ommen; Johan T den Dunnen; Alt Zantema; Peter A C 't Hoen
Journal:  Nucleic Acids Res       Date:  2010-04-30       Impact factor: 16.971

9.  Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.

Authors:  Markus Diefenbacher; Sylwia Sekula; Christine Heilbock; Jana V Maier; Margarethe Litfin; Hans van Dam; Marc Castellazzi; Peter Herrlich; Olivier Kassel
Journal:  Mol Endocrinol       Date:  2008-06-05

10.  Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38.

Authors:  D Margriet Ouwens; Nancy D de Ruiter; Gerard C M van der Zon; Andrew P Carter; Jan Schouten; Corina van der Burgt; Klaas Kooistra; Johannes L Bos; J Antonie Maassen; Hans van Dam
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.